Skip to content
Search AI Powered

Latest Stories

Covid-19 lockdown having an effect: Study  

Data gathered from two million people in Britain using a new Covid-19 symptom tracker app suggests lockdown measures are slowing the spread of the disease, researchers said on Wednesday (8).

The rate of new coronavirus symptoms reported in Britain has slowed significantly in the past few days, the King’s College London scientists said.


Their latest figures suggest that around 1.4 million people in Britain aged between 20 and 69 currently have symptomatic Covid-19, a fall from 1.9 million on April 1, as some have recovered and fewer people report new symptoms.

The drop in new symptoms suggests that although the numbers of Covid-19 patients being admitted to hospital are rising, as are the numbers dying, these should start to fall in about two weeks if social distancing measures are kept in place.

Official figures show Britain's total hospital deaths from Covid-19 rose by 786 to 6,159 as of 1600 GMT on Monday (6).

Like many other countries hit by the pandemic, Britain has imposed strict social distancing along with shop and school closures. Introducing the measures more than two weeks ago, authorities also asked everyone to stay at home except for essential travel.

Tim Spector, who led the King's team analysing the symptom tracker data, said the signs were "encouraging".

"Even though hospital admissions and deaths are still on the rise, we hope that these figures offer a much needed light at the end of the tunnel," he said.

Spector's analysis comes after preliminary work by researchers at the London School of Hygiene and Tropical Medicine published a week ago also showed that social distancing may already be working by dramatically reducing the number of daily contacts between people.

Spector said his data showed, however, that Britain's larger cities like London, Birmingham, Glasgow and Liverpool "continue to have very high levels of symptoms in the community".

London Mayor Sadiq Khan said on Wednesday that Britain is in no position to ease the shutdown as the peak of the Covid -19 outbreak is still likely to be more than a week away.

More For You

Sigma Conference: "Pharmacists need greater role in integrated care boards," says CPE representative

Prakash Patel was speaking at a panel discussion at the Sigma Conference

Sigma Conference: "Pharmacists need greater role in integrated care boards," says CPE representative

Pharmacists need to be a part of integrated care boards (ICB) to stop GPs from monopolising services based on their needs rather than the needs of the patient, according to Prakash Patel, Community Pharmacy Engaland (CPE) representative for North London.

“The evolution of the NHS should mean there can be no decision of pharmacy without pharmacist,” Patel told delegates at the Sigma Pharmacy Conference in Baku, Azerbaijan on Tuesday.

Keep ReadingShow less
New professional liability insurance policy for RPS members launched

The insurance will be provided to members at cost, with no profit made by RPS.

gettyimages

RPS launches professional liability insurance for members

The Royal Pharmaceutical Society (RPS) has launched a new professional liability insurance policy, designed to empower pharmacists to work confidently and deliver high-quality care, knowing they are protected.

Exclusively available to its members, the comprehensive and affordable insurance has been developed in collaboration with global professional services firm Aon.

Keep ReadingShow less
Cargo plane unloading pharmaceuticals at US airport amid tariff concerns and stockpiling

Imports jumped in particular from Ireland, the top drug exporter to the US

Pic credit: iStock

Pharma imports to US surged in March as drugmakers look to avoid tariffs

Pharmaceutical imports to the US surged in March as drugmakers stocked up ahead of potential US tariffs on their products, which have historically been exempt from such fees.

Total imports of pharmaceutical products exceeded $50 billion in the month - the equivalent of 20 per cent of all pharmaceutical imports in 2024, according to data from a U.S. Commerce Department report on Tuesday.

Keep ReadingShow less
Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less